+ Watch FMI
on My Watchlist
P/B on the high side but over 12% insider ownership and good Q/Q numbers make up for that.
If it's good enough for Google Ventures to be investing in, it's good enough for me. This pick is for fun!
The future is... here
This could be the surprise of 2014. I believe it will get added to Medicare funding and Insurance Companies dockets, once that happens revenue and earnings will take off and so will this stock. Stay tuned………………….
Speculation on an IPO. Here's its profile:"Foundation Medicine, Inc. provides various molecular information products in the United States. Its molecular information platform generates actionable genomic information about a patient?s individual disease, enabling physicians to optimize treatments in clinical practice, and enabling biopharmaceutical companies to develop targeted oncology therapies. The company offers FoundationOne, a molecular information product for the analysis of routine cancer specimens in a clinical setting. It is also developing FoundationOne for hematologic malignancies."
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions